Top Suppliers:I want be here


157124-84-0

157124-84-0 structure
157124-84-0 structure

Name BPH-652
Description BPH-652 is a S. aureus dehydrosqualene synthase (CrtM) inhibitor, with a Ki of 1.5 nM and an IC50 of 100-300 nM (S. aureus pigment formation)[1].
Related Catalog
Target

Ki: 1.5 nM (CrtM). IC50: 100-300 nM (S. aureus pigment formation)[1].

In Vivo BPH-652 treatment (0.5 mg twice per day (days −1, 0, 1, and 2), Intraperitoneal injection) significantly lowers S. aureus bacterial counts in the kidneys of the mice than those of the control group (P < 0.001), with 8 of 13 below the detection threshold, versus only 2 of 14 in the control group; on average, this result corresponds to a 98% decrease in surviving bacteria in the treatment group[1]. Animal Model: A systemic S. aureus infection model in mice[1]. Dosage: 0.5 mg twice per day (days −1, 0, 1, and 2). Administration: Intraperitoneal injection. Result: S. aureus bacterial counts in the kidneys of the mice treated with BPH-652 were significantly lower than those of the control group.
References

[1]. Liu CI, et al. A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence. Science. 2008 Mar 7;319(5868):1391-4.

Molecular Formula C16H16K3O7PS
Molecular Weight 500.63
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.